Key result
Effective thrombosis management requires dynamic antithrombotic regimens tailored to mechanism, timing, and bleeding risk.
Why the study?
Management of thrombosis across cardiovascular conditions requires integration of thrombotic mechanisms, timing, risk stratification, and bleeding vulnerability, but evidence remains limited for vulnerable populations and uncommon settings.
Highlights contemporary antithrombotic strategies across cardiovascular diseases, indicating that tailored therapy balances ischemic protection against bleeding risk.
CA extern
No takes yet. Share an insight, caveat, or question.
Gragnano et al. (2026) conducted a review in Thrombosis and cardiovascular disease. Antithrombotic therapy was evaluated. Recent evidence emphasizes that effective management of thrombosis requires a dynamic approach, tailoring antithrombotic therapy to the underlying mechanism, timing, and individual bleeding risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: